Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial

被引:53
|
作者
Beaumont, Marc [1 ]
Mialon, Philippe [2 ]
Le Ber, Catherine [1 ]
Le Mevel, Patricia [1 ]
Peran, Loic [1 ]
Meurisse, Olivier [1 ]
Morelot-Panzini, Capucine [3 ]
Dion, Angelina [4 ]
Couturaud, Francis [5 ]
机构
[1] European Univ Occidental Brittany, EA3878, Morlaix Hosp Ctr, Pulm Rehabil Unit, Morlaix, France
[2] European Univ Occidental Brittany, Univ Brest Ctr, EA2438, Pulm Physiol Unit, Brest, France
[3] Hop La Pitie Salpetriere, Pulm & Reanimat Unit, Paris, France
[4] Univ Hosp Brest, INSERM CIC 1412, Brest, France
[5] European Univ Occidental Brittany, Univ Hosp Brest, Dept Internal Med & Chest Dis, GETBO EA3878,CIC INSERM 1412, Brest, France
关键词
RESPIRATORY SOCIETY STATEMENT; DYNAMIC HYPERINFLATION; EXERCISE PERFORMANCE; CYCLE ERGOMETER; BREATHLESSNESS; INTOLERANCE; CAPACITY; DISEASE; UPDATE;
D O I
10.1183/13993003.01107-2017
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The benefit of inspiratory muscle training (IMT) combined with a pulmonary rehabilitation programme (PRP) is uncertain. We aimed to demonstrate that, in severe and very severe chronic obstructive pulmonary disease (COPD) patients, IMT performed during a PRP is associated with an improvement of dyspnoea. In a single-blind randomised controlled trial, 150 severe or very severe COPD patients were allocated to follow PRP+IMT versus PRP alone. The evaluations were performed at inclusion and after 4 weeks. The primary outcome was the change in dyspnoea using the Multidimensional Dyspnoea Profile questionnaire at the end of a 6-min walk test (6MWT) at 4 weeks. Secondary outcomes were changes in dyspnoea using the Borg (end of the 6MWT) and modified Medical Research Council scales and in functional parameters (maximal inspiratory pressure (PImax), inspiratory capacity, 6MWT and quality of life). All analyses were performed on an intention-to-treat basis. Dyspnoea decreased significantly in both groups; however, the improvement of dyspnoea was not statistically different between the two groups. We only found a statistically significant greater increase of PImax after IMT+PRP than after PRP alone. In this trial including severe or very severe COPD patients, we did not find a significant benefit of IMT during PRP+IMT as compared to PRP alone on dyspnoea, despite a significantly higher improvement of PImax in the IMT group.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] A multicentre randomised controlled trial of inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study)
    Charususin, Noppawan
    Gosselink, Rik
    Decramer, Marc
    McConnell, Alison
    Demeyer, Heleen
    Saey, Didier
    Maltais, Francois
    Derom, Eric
    Vermeersch, Stefanie
    Heijdra, Yvonne
    Garms, Linda
    Gloeckl, Rainer
    Kenn, Klaus
    Langer, Daniel
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [22] Inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study): A multicentre randomised controlled trial
    Charususin, Noppawan
    Gosselink, Rik
    Decramer, Marc
    McConnell, Alison
    Saey, Didier
    Maltais, Francois
    Derom, Eric
    Vermeersch, Stefanie
    Heijdra, Yvonne
    Garms, Linda
    Gloeckl, Rainer
    Kenn, Klaus
    Langer, Daniel
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [23] Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial
    Schultz, Konrad
    Jelusic, Danijel
    Wittmann, Michael
    Kraemer, Benjamin
    Huber, Veronika
    Fuchs, Sebastian
    Lehbert, Nicola
    Wingart, Silke
    Stojanovic, Dragan
    Goehl, Oliver
    Alma, Harma J.
    de Jong, Corina
    van der Molen, Thys
    Faller, Hermann
    Schuler, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (01)
  • [24] Effects of routine inspiratory muscle training (IMT) as add-on to pulmonary rehabilitation (PR) in COPD
    Schultz, Konrad
    Kraemer, Benjamin
    Fuchs, Sebastian
    Wingart, Silke
    Lehbert, Nicola
    Huber, Veronika
    Stojanovic, Dragan
    Wittmann, Michael
    Jelusic, Danijel
    Schuler, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] Effects of controlled inspiratory muscle training in patients with COPD:: a meta-analysis
    Lötters, F
    van Tol, B
    Kwakkel, G
    Gosselinko, R
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (03) : 570 - 576
  • [26] The effects of inspiratory muscle warm-up prior to inspiratory muscle training during pulmonary rehabilitation in subjects with chronic obstructive pulmonary disease: a randomized trial
    Aktan, Ridvan
    Ozalevli, Sevgi
    Yakut, Hazal
    Alpaydin, Aylin Ozgen
    PHYSIOTHERAPY THEORY AND PRACTICE, 2025, 41 (01) : 1 - 11
  • [27] TARGET-FLOW INSPIRATORY MUSCLE TRAINING AT HOME AND DURING PULMONARY REHABILITATION IN COPD PATIENTS WITH A VENTILATORY LIMITATION DURING EXERCISE
    DEKHUIJZEN, PNR
    FOLGERING, HTM
    VANHERWAARDEN, CLA
    LUNG, 1990, 168 : 502 - 508
  • [28] A Randomized Controlled Trial of Balance Training During Pulmonary Rehabilitation for Individuals With COPD
    Beauchamp, Marla K.
    Janaudis-Ferreira, Tania
    Parreira, Veronica
    Romano, Julia M.
    Woon, Lynda
    Goldstein, Roger S.
    Brooks, Dina
    CHEST, 2013, 144 (06) : 1803 - 1810
  • [29] EFFECTS OF INSPIRATORY MUSCLE TRAINING WITH PFLEX IN COPD PATIENTS
    WALCZAK, J
    CHODOSOWSKA, E
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S43 - S43
  • [30] Additional Effects of Nutritional Antioxidant Supplementation on Peripheral Muscle during Pulmonary Rehabilitation in COPD Patients: A Randomized Controlled Trial
    Gouzi, Fares
    Maury, Jonathan
    Heraud, Nelly
    Molinari, Nicolas
    Bertet, Helena
    Ayoub, Bronia
    Blaquiere, Marine
    Bughin, Francois
    De Rigal, Philippe
    Poulain, Magali
    Pincemail, Joel
    Cristol, Jean-Paul
    Laoudj-Chenivesse, Dalila
    Mercier, Jacques
    Prefaut, Christian
    Pomies, Pascal
    Hayot, Maurice
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019